Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of two residual DNA quantification (RDQ) kits to simplify the quantification of host-cell DNA (HCD) in process development, ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the recent launch of the Vericheck ddPCR™ Replication ...

We recently published a list of Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential. In this article, ...

The new kits offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes, for use in either flow ...

Bio-Rad Laboratories, Inc. manufactures and distributes ... informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician ...

Bio-Rad Laboratories, Inc.’s BIO share price has dipped by 5.31%, which has investors questioning if this is right time to ...

In its first-quarter 2025 investor letter, Longleaf Partners Fund highlighted stocks such as Bio-Rad Laboratories, Inc. (NYSE:BIO). Bio-Rad Laboratories, Inc. (NYSE:BIO) is a life science company ...